trickthefox
Senior Member
- Messages
- 212
- Location
- Brighton
No offence, but you sound like you had your head in the sand, there are literally hundreds of studies on stem cells in areas other than immune regeneration after chemo, i have conversed with quite a few doctors working in this field, and watched many talks on them. Saying 'people get better for a number of reasons' when you have had someone sick for years, trying various treatment modalities like antibiotics, only to get better months after a stem cell procedure sounds like someone who doesn't want to believe in them working. Spontanous recovery from lyme/autoimmune/M.E. is very rare in my experience.
There are a number of explanations why the stem cells may be helping, not necisarily because they are directly replacing damaged cells or tissue, but because they can influence deffective B/T cell responses and help quiet inflamation until homeostasis is resumed.
"Mesenchymal stem cells (MSCs) are now known to display not only stem cell multipotency, but also robust antiinflammatory and regenerative properties. After widespread in-vitro and in-vivo preclinical testing, autologous and allogeneic MSCs have been applied in a range of immune mediated conditions, including graft versus host disease, Crohn's disease, multiple sclerosis, refractory systemic lupus erythematosus and systemic sclerosis. Current data suggests that MSCs may not only replace diseased tissues, but also exert several trophic, regenerative and antiinflammatory effects. "
There are a number of explanations why the stem cells may be helping, not necisarily because they are directly replacing damaged cells or tissue, but because they can influence deffective B/T cell responses and help quiet inflamation until homeostasis is resumed.
"Mesenchymal stem cells (MSCs) are now known to display not only stem cell multipotency, but also robust antiinflammatory and regenerative properties. After widespread in-vitro and in-vivo preclinical testing, autologous and allogeneic MSCs have been applied in a range of immune mediated conditions, including graft versus host disease, Crohn's disease, multiple sclerosis, refractory systemic lupus erythematosus and systemic sclerosis. Current data suggests that MSCs may not only replace diseased tissues, but also exert several trophic, regenerative and antiinflammatory effects. "